MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

PURPOSE: To develop a risk score for patients with advanced systemic mastocytosis (AdvSM) that integrates clinical and mutation characteristics. PATIENTS AND METHODS: The study included 383 patients with AdvSM from the German Registry on Disorders of Eosinophils and Mast Cells (training set; n = 231...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Jawhar, Mohamad, Schwaab, Juliana, Álvarez-Twose, Iván, Shoumariyeh, Khalid, Naumann, Nicole, Lübke, Johannes, Perkins, Cecelia, Muñoz-González, Javier I., Meggendorfer, Manja, Kennedy, Vanessa, Metzgeroth, Georgia, Fabarius, Alice, Pfeifer, Dietmar, Sotlar, Karl, Horny, Hans-Peter, von Bubnoff, Nikolas, Haferlach, Torsten, Cross, Nicholas C.P., Hofmann, Wolf-Karsten, Sperr, Wolfgang R., García-Montero, Andrés C., Valent, Peter, Gotlib, Jason, Orfao, Alberto, Reiter, Andreas
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6823885/
https://ncbi.nlm.nih.gov/pubmed/31509472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados